Osmed Formulations Private Limited, a active private limited company, was established on 08 September 1999 in Ujjain, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231MP1999PTC013737. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.14 Cr.
It upholds a compliant status. Employing 86 professional, Its leadership includes Nipun Maheshwari (Whole-Time Director), Pankaj Maheshwari (Director). Past directors included Mangilal Maheshwari, Piyush Maheshwari, Nipun Maheshwari. It holds ₹5.00 Cr open charges and ₹5.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 56-57, Indudtrial Area, Maxi Road, Ujjain, Madhya Pradesh, 456010.
U24231MP1999PTC013737
013737
08 September 1999
₹5.00 Cr
₹3.14 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Osmed Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nipun Maheshwari | Whole-Time Director | 05 Aug 2014 | Current |
| Pankaj Maheshwari | Director | 04 May 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 01 Apr 2020 | Past |
| Pramod Abcsdd | Director | 05 Aug 2014 | Past |
| Pramod Abcsdd | Director | 01 Oct 2014 | Past |
| Pramod Abcsdd | Director | 21 Mar 2014 | Past |
| Pramod Abcsdd | Whole-Time Director | 01 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Osmed Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.53% increase. The company also saw a substantial improvement in profitability, with a 30.28% increase in profit. The company's net worth Soared by an impressive increase of 28.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Osmed Formulations had a promoter holding of 53.54% and a public holding of 46.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹5,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2004 | Others | ₹5.00 Cr | Open |
| 03 Aug 2007 | M. P. Financial Corporation | ₹2.50 M | Satisfied |
| 29 Mar 2001 | M. P. Financial Corporation | ₹3.00 M | Satisfied |
Explore comprehensive loan charge details -
Osmed Formulations has a workforce of 86 employees as of Mar 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Osmed Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Osmed Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Osmed Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Pankaj Maheshwari was appointed as a Director was appointed as a Director on 04 May 2024 & has been associated with this company since 1 year 7 months . was completed.
Progress on Osmed Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was documented.
Progress on A charge with Others of Rs. 5.00 Cr registered on 26 Mar 2004 with Charge ID 90209533 was modified on 10 Jul 2019. was documented.
Nipun Maheshwari was appointed as a Whole-time director was appointed as a Whole-time director on 05 Aug 2014 & has been associated with this company since 11 years 4 months . was recorded as a recent event.
The activity A charge registered on 03 Aug 2007 via Charge ID 10066166 with M. P. Financial Corporation was fully satisfied on 17 Jan 2014. was completed.
The CIN of Osmed Formulations Private Limited is U24231MP1999PTC013737.
Osmed Formulations Private Limited is headquartered at 56-57, Indudtrial Area, Maxi Road, Ujjain, Madhya Pradesh, 456010.
Osmed Formulations Private Limited was incorporated on 08 September 1999.
The current directors of Osmed Formulations Private Limited are
The primary industry of Osmed Formulations Private Limited is Manufacturing.
Osmed Formulations Private Limited is unlisted.
The authorized capital of Osmed Formulations Private Limited is ₹5.00 Cr, and the paid-up capital is ₹3.14 Cr.
The compliance status of Osmed Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX